Form 4 for COYA Coya Therapeutics, Inc.
Accepted 2023-01-04 00:00:00 ET · period of report 2023-01-03 · accession 0001493152-23-000224 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-04 | 2023-01-03 | COYA | SNYDER DAVID S | CFO | P - Purchase | — | +7,000 | 7,000 | New | — |
| D | 2023-01-04 | 2023-01-03 | COYA | SNYDER DAVID S | CFO | P - Purchase | — | +3,500 | 3,500 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2023-01-03 | P | A | 7,000 | — | 7,000 | D | — | — | (F1) Reporting Person purchased 7,000 shares of Common Stock and an accompanying warrant to purchase 3,500 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant. |
| 2 | Derivative | Warrant to Purchase Common Stock | 2023-01-03 | P | A | 3,500 | — | 3,500 | D | $7.50 · 2023-01-03 to 2025-01-03 | 3,500 Common Stock, par value $0.0001 per share | (F1) Reporting Person purchased 7,000 shares of Common Stock and an accompanying warrant to purchase 3,500 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant. |